Author Archive: BIOtechNOW Editor

Analysis and Impact of PDUFA V

hamburg

As the House of Representatives voted unanimously to approve legislation to approve the Prescription Drug User Fee Act (PDUFA) V, industry leaders gathered at the 2012 BIO International Convention for a lively discussion on the changes the new legislation, focused on modernizing Food and Drug Administration regulations, will bring to the biotechnology industry. The super session panel discussion was moderated by Steve Usdin, Washington Editor of BioCentury and Co-Host of BioCentury This Week, and included Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

BIO 2012 Super Session Recap: Burrill State-of-the-Industry Report

Business Forum

“How are we doing? It’s tough.” That’s what G. Steven Burrill, CEO of Burrill & Company, said at the outset of his talk to a fully packed room at the 2012 BIO International Convention Super Session featuring an overview of the 26th annual Burrill State-of-the-Industry Report. The report’s main finding was that the biotech industry is changing at a rapid pace, and is confronting a significant and newfound adversity in austerity that is caused by Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Cancer Research Pioneer Dr. Margaret Foti named 2012 Biotech Humanitarian Honoree

Dr. Margaret Foti

Today, BIO named Dr. Margaret Foti, , Ph.D., M.D. (h.c.), CEO of the American Association of Cancer Research, as the 2012 Biotech Humanitarian Honoree.  Dr. Foti was honored for her tireless efforts to improve cancer research, her work as a cancer advocate and her ground-breaking work in the area of team science. Dr. Foti is also known for her work leading AACR’s scientific partnership with Stand Up To Cancer — a charitable initiative that supports Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Americans, Biotech Execs, Convention Attendees Optimistic About Biotech

Key Findings From A  National Survey Of Voters

What does the future hold for biotechnology? After surveying American voters, biotech executives, and attendees here the 2012 BIO International Convention, we learned that the future is indeed bright.  More than three quarters of American voters, nearly all the biotech execs, and 1,400 of the attendees we spoke to are optimistic that science and technology will find cures to help patients suffering from serious diseases, such as cancer, diabetes, Alzheimer’s, Parkinson’s and HIV/AIDS. Tempering that Read More >

Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

An Insider’s View of the BioGENEius Challenge

BioGENEius Challenge

By Erica Hiar, Environics A big highlight every year for many attendees at BIO International Convention is the announcement of the winner of the International BioGENEius Challenge, a competition for high school students who demonstrate an exemplary understanding of biotechnology through science research projects. But for me, the true excitement was the ride getting there. Four hundred thirty-five students applied for the U.S. International BioGENEius challenge and hundreds more applied to the Canadian and Western Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , ,